Publications & Posters
Scholary publications
Spinal Muscular Atrophy
Apitegromab
March 2020
MDA Clinical and Scientific Conference
A Phase 2 Study to Evaluate the Efficacy and Safety of SRK-015 in Patients with Later-Onset Spinal Muscular Atrophy (TOPAZ): An Introduction
Spinal Muscular Atrophy
Apitegromab
February 2020
SMA Europe
A Phase 2 Study to Evaluate the Efficacy and Safety of SRK-015 in Patients with Later-Onset Spinal Muscular Atrophy (TOPAZ): An Introduction
Spinal Muscular Atrophy
Apitegromab
February 2020
SMA Europe
Clinical Development of SRK-015, a Fully Human Anti-proMyostatin Monoclonal Antibody, for the Treatment of Later-Onset Spinal Muscular Atrophy
Spinal Muscular Atrophy
Apitegromab
October 2019
World Muscle Society Congress
SRK-015, a Fully Human Monoclonal Antibody Inhibiting Myostatin Activation, Offers Sustained Target Engagement Across Multiple Species, Including Humans
Spinal Muscular Atrophy
Apitegromab
July 2019
SLAS Discovery
A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation
Immuno-Oncology
SRK-181
April 2019
American Association for Cancer Research (AACR) Annual Meeting
